Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M L Moore

Showing results (91-100 of 108) with videos related to

Pageof 11
Sort By:
Journal of Medicinal Chemistry|August 1, 1988
Dicarbavasopressin antagonist analogues exhibit reduced in vivo agonist activityM L Moore, C Albrightson, B Brickson, et al.
Journal of Medicinal Chemistry|December 1, 1986
Potent antagonists of vasopressin antidiuretic activity that lack the beta,beta-cyclopentamethylene-beta-mercaptopropionic acid substitution at position 1N C Yim, M L Moore, W F Huffman, et al.
Biochemistry|November 6, 1992
Proteolysis of an active site peptide of lactate dehydrogenase by human immunodeficiency virus type 1 proteaseT A Tomaszek, M L Moore, J E Strickler, et al.
Journal of Medicinal Chemistry|August 18, 1995
A check on rational drug design: crystal structure of a complex of human immunodeficiency virus type 1 protease with a novel gamma-turn mimetic inhibitorS S Hoog, B Zhao, E Winborne, et al.
Journal of Medicinal Chemistry|April 1, 1989
A minor modification of residue 1 in potent vasopressin antagonists dramatically reduces agonist activityW F Huffman, C Albrightson-Winslow, B Brickson, et al.
Journal of Medicinal Chemistry|April 1, 1988
Design, synthesis, and biological activity of a peptide mimic of vasopressinW M Bryan, J C Hempel, W F Huffman, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1991
Vasopressin antidiuretic agonist and antagonist activity in dogs: structural and stereochemical relationship between bridge and carboxyl terminusC R Albrightson-Winslow, B Brickson, D P Brooks, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1989
Human immunodeficiency virus 1 protease expressed in Escherichia coli behaves as a dimeric aspartic proteaseT D Meek, B D Dayton, B W Metcalf, et al.
Nature|January 14, 1990
Inhibition of HIV-1 protease in infected T-lymphocytes by synthetic peptide analoguesT D Meek, D M Lambert, G B Dreyer, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1989
Inhibition of human immunodeficiency virus 1 protease in vitro: rational design of substrate analogue inhibitorsG B Dreyer, B W Metcalf, T A Tomaszek, et al.
Pageof 11

Showing results (91-100 of 108) with videos related to

Sort By:
Pageof 11
Journal of Medicinal Chemistry|August 1, 1988
Dicarbavasopressin antagonist analogues exhibit reduced in vivo agonist activityM L Moore, C Albrightson, B Brickson, et al.
Journal of Medicinal Chemistry|December 1, 1986
Potent antagonists of vasopressin antidiuretic activity that lack the beta,beta-cyclopentamethylene-beta-mercaptopropionic acid substitution at position 1N C Yim, M L Moore, W F Huffman, et al.
Biochemistry|November 6, 1992
Proteolysis of an active site peptide of lactate dehydrogenase by human immunodeficiency virus type 1 proteaseT A Tomaszek, M L Moore, J E Strickler, et al.
Journal of Medicinal Chemistry|August 18, 1995
A check on rational drug design: crystal structure of a complex of human immunodeficiency virus type 1 protease with a novel gamma-turn mimetic inhibitorS S Hoog, B Zhao, E Winborne, et al.
Journal of Medicinal Chemistry|April 1, 1989
A minor modification of residue 1 in potent vasopressin antagonists dramatically reduces agonist activityW F Huffman, C Albrightson-Winslow, B Brickson, et al.
Journal of Medicinal Chemistry|April 1, 1988
Design, synthesis, and biological activity of a peptide mimic of vasopressinW M Bryan, J C Hempel, W F Huffman, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1991
Vasopressin antidiuretic agonist and antagonist activity in dogs: structural and stereochemical relationship between bridge and carboxyl terminusC R Albrightson-Winslow, B Brickson, D P Brooks, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1989
Human immunodeficiency virus 1 protease expressed in Escherichia coli behaves as a dimeric aspartic proteaseT D Meek, B D Dayton, B W Metcalf, et al.
Nature|January 14, 1990
Inhibition of HIV-1 protease in infected T-lymphocytes by synthetic peptide analoguesT D Meek, D M Lambert, G B Dreyer, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1989
Inhibition of human immunodeficiency virus 1 protease in vitro: rational design of substrate analogue inhibitorsG B Dreyer, B W Metcalf, T A Tomaszek, et al.
Pageof 11